You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Refractory Ewing Sarcoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Ewing Sarcoma, Relapsed Ewing Sarcoma, Ewing Sarcoma Trial (Lurbinectedin)

Not yet recruiting
  • Refractory Ewing Sarcoma
  • +2 more
  • (no location specified)
Feb 15, 2023

Ewing Sarcoma Trial in Warsaw (Naxitamab)

Not yet recruiting
  • Ewing Sarcoma
  • Warsaw, Mazowian, Poland
    Mother and Child Institute
Jul 28, 2023

Ewing Sarcoma, Osteosarcoma Trial in San Francisco, Aurora, Philadelphia (Cabozantinib)

Recruiting
  • Ewing Sarcoma
  • Osteosarcoma
  • San Francisco, California
  • +4 more
Nov 24, 2023

Ewing Sarcoma, Ewing-Like Sarcoma Trial in New York (LY2880070, Gemcitabine)

Recruiting
  • Ewing Sarcoma
  • Ewing-Like Sarcoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Aug 18, 2022

Sarcoma, Ewing Trial in China (TK216+Vincristin)

Not yet recruiting
  • Sarcoma, Ewing
  • TK216+Vincristin
  • Beijing, Beijing, China
  • +7 more
Jul 25, 2022

Ewing Sarcoma, Ewing's Sarcoma Recurrent Trial in Boston (Palbociclib, Ganitumab)

Active, not recruiting
  • Ewing Sarcoma
  • Ewing's Sarcoma Recurrent
  • Boston, Massachusetts
  • +2 more
Mar 21, 2022

Recurrent Solid Tumor, Recurrent Ewing Sarcoma, Recurrent Hepatoblastoma Trial in Canada, United States (Onivyde, Talazoparib,

Recruiting
  • Recurrent Solid Tumor
  • +21 more
  • Palo Alto, California
  • +8 more
Jun 7, 2022

Relapsed Ewing Sarcoma, Refractory Ewing Sarcoma, Relapsed Osteosarcoma Trial in Boston (Cabozantinib, Topotecan,

Recruiting
  • Relapsed Ewing Sarcoma
  • +3 more
  • Boston, Massachusetts
  • +1 more
Sep 27, 2021

Sarcoma, Ewing, Rhabdomyosarcoma Trial run by the National Cancer Institute (NCI) (PEN-866, Vincristine, Temozolomide)

Not yet recruiting
  • Sarcoma, Ewing
  • Rhabdomyosarcoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Ewing Sarcoma, Myxoid Liposarcoma, Sarcoma,Soft Tissue Trial in United States (Seclidemstat, Cyclophosphamide, Topotecan)

Recruiting
  • Ewing Sarcoma
  • +10 more
  • Los Angeles, California
  • +16 more
Jan 18, 2022

Tumor, Desmoplastic Small Round Cell, Adult, Tumor, Desmoplastic Small Round Cell, Childhood, Sarcoma, Ewing Trial in Spain (nab

Completed
  • Tumor, Desmoplastic Small Round Cell, Adult
  • +4 more
  • nab paclitaxel
  • Barcelona, Spain
  • +6 more
Jun 6, 2022

Osteosarcoma, Ewing Sarcoma of Bone Trial in Warsaw (Regorafenib)

Recruiting
  • Osteosarcoma
  • Ewing Sarcoma of Bone
  • Warsaw, Mazovian, Poland
    Mother and Child Institute
Sep 7, 2022

Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)

Recruiting
  • Colorectal Carcinoma
  • +21 more
  • Dual X-ray Absorptiometry
  • +2 more
  • Birmingham, Alabama
  • +18 more
Jan 30, 2023

Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor Trial in Valhalla (Vorinostat)

Recruiting
  • Ewing Sarcoma
  • +5 more
  • Valhalla, New York
    New York Medical College
Oct 24, 2022

Recurrent Alveolar Rhabdomyosarcoma, Recurrent Ewing Sarcoma, Recurrent Lymphoma Trial in United States (Elimusertib)

Recruiting
  • Recurrent Alveolar Rhabdomyosarcoma
  • +7 more
  • Birmingham, Alabama
  • +28 more
Jan 26, 2023

Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in

Active, not recruiting
Has Results
  • Metastatic Melanoma
  • +22 more
  • Ipilimumab
  • +3 more
  • Birmingham, Alabama
  • +24 more
Jan 19, 2023

Neuroblastoma, Neuroblastoma Recurrent, GD2-positive Solid Tumors Trial in Roma (GD2-CART01)

Recruiting
  • Neuroblastoma
  • +5 more
  • GD2-CART01
  • Roma, Italy
    Ospedale Pediatrico Bambino Gesù
Mar 9, 2022

Sarcoma, Ewing, Tumor Metastasis Trial in Worldwide (Abemaciclib, Irinotecan, Temozolomide)

Not yet recruiting
  • Sarcoma, Ewing
  • Neoplasm Metastasis
  • Phoenix, Arizona
  • +29 more
Aug 17, 2022

Osteosarcoma, Ewing Sarcoma, Rhabdomyosarcoma Trial in Washington (Cryoablation Therapy, Nivolumab, Ipilimumab)

Recruiting
  • Osteosarcoma
  • +9 more
  • Cryoablation Therapy
  • +2 more
  • Washington, District of Columbia
    Children's National Hospital
Mar 21, 2022

Solid Tumor, Lymphoma, Osteosarcoma Trial in Orange (Surufatinib in combination with Gemcitabine)

Recruiting
  • Solid Tumor
  • +5 more
  • Surufatinib in combination with Gemcitabine
  • Orange, California
    Childrens Hospital Orange County
Feb 8, 2022

Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second

Recruiting
  • Pediatric Solid Tumor
  • +15 more
  • second generation 4-1BBζ EGFR806-EGFRt
  • second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
  • Seattle, Washington
    Seattle Children's Hospital
May 2, 2022

Solid Tumors, Soft Tissue Sarcoma, Ewing Sarcoma Trial (Magnetic Resonance-Guided High Intensity Focused Ultrasound,

Not yet recruiting
  • Solid Tumors
  • +8 more
  • Magnetic Resonance-Guided High Intensity Focused Ultrasound
  • Lyso-thermosensitive Liposomal Doxorubicin
  • (no location specified)
Mar 10, 2022

Relapsed/Refractory Rhabdomyosarcoma, Non-rhabdomyosarcoma Soft Tissue Sarcoma, Ewing Sarcoma Trial in United States (Eribulin

Completed
Has Results
  • Relapsed/Refractory Rhabdomyosarcoma
  • +2 more
  • Eribulin mesylate
  • Birmingham, Alabama
  • +40 more
Mar 18, 2022

Relapsed Pediatric Solid Tumors, Refractory Pediatric Solid Tumors, Rhabdomyosarcoma Trial in Washington, Cincinnati (Magnetic

Active, not recruiting
  • Relapsed Pediatric Solid Tumors
  • +9 more
  • Magnetic Resonance High Intensity Focused Ultrasound
  • Washington, District of Columbia
  • +1 more
Jan 21, 2022

Pediatric Cancer, Solid Tumors, Rhabdomyosarcoma Trial in Washington (Magnetic resonance high intensity focused ultrasound,

Recruiting
  • Pediatric Cancer
  • +9 more
  • Magnetic resonance high intensity focused ultrasound
  • Lyso-thermosensitive liposomal doxorubicin
  • Washington, District of Columbia
    Children's National Medical Center
Dec 10, 2021